Neurology News and Research

Latest Neurology News and Research

Researchers confirm strong bidirectional relation between epilepsy, schizophrenia

Researchers from Taiwan have confirmed a bidirectional relation between schizophrenia and epilepsy. The study published today in Epilepsia, a journal of the International League Against Epilepsy (ILAE), reports that patients with epilepsy were nearly 8 times more likely to develop schizophrenia and those with schizophrenia were close to 6 times more likely to develop epilepsy.

19 Sep 2011

ALS damages neurons in parts of the brain responsible for cognition and behaviour

Recently published studies by a researcher in the Faculty of Medicine & Dentistry demonstrate that ALS - known as Lou Gehrig's disease - damages neurons in parts of the brain responsible for cognition and behaviour.

17 Sep 2011

Simple strategies prevent bloodstream infections and save hundreds of patient lives

Following some basic rules of central line hygiene and maintenance, Johns Hopkins Children's Center and 87 other pediatric hospitals have, over five years, saved hundreds of patient lives and more than $100 million by preventing nearly 3,000 central line bloodstream infections, hospital officials announced on Monday, Sept. 12.

16 Sep 2011

Policies needed to prepare individuals, society for earlier diagnosis and high risk of Alzheimer's

The changing tide of Alzheimer's diagnosis presents new challenges to the public, physicians and lawmakers: if you could find out your Alzheimer's risk, would you want to know? How should doctors tell you your risk? And what does it mean for the many newly diagnosed Americans still in the workplace?

16 Sep 2011

CHAM experts available to discuss variety of back-to-school issues

Experts from The Children's Hospital at Montefiore (CHAM) are available for interviews on a variety of back-to-school issues.

16 Sep 2011

Hypnosis to tackle problems of chronic pain: International expert

A visiting international rehabilitation expert has called for Hypnotic Therapy to be considered a ‘mainstream’ treatment option in the management of chronic pain, potentially benefiting thousands of Australian pain sufferers.

15 Sep 2011

BGU study: Voting causes stress and induces measurable hormonal changes

As the United States nears another election day, researchers at Ben-Gurion University of the Negev (BGU) have determined scientifically, for the first time, that voting is a stressful event, inducing measurable hormonal changes.

15 Sep 2011

Telestroke appears to be cost-effective for rural hospitals

In a first of its kind study, researchers have found that using two way audio-video telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist, or stroke expert, on staff.

15 Sep 2011

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Alexion Pharmaceuticals, Inc. today announced that the Company's study of eculizumab in a small group of 14 patients with severe and refractory generalized myasthenia gravis, an ultra-rare and debilitating form of generalized myasthenia gravis (gMG), showed a strong disease improvement signal.

15 Sep 2011

Researchers discover several chemical compounds against human prion diseases

In a new study NYU School of Medicine researchers report that they have found several chemical compounds, including an antidepressant, that have powerful effects against brain-destroying prion infections in mice, opening the door to potential treatments for human prion diseases.

15 Sep 2011

Jefferson neurologist receives Harold G. Wolff Lecture Award for migraine headache model

Michael L. Oshinsky, Ph.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and a member of the Jefferson Headache Center team, was recently named the 2011 Harold G. Wolff Lecture award recipient for creating a new animal model of migraine headache.

14 Sep 2011

High cholesterol and Alzheimer's disease

New research suggests that high cholesterol levels could boost the risk of Alzheimer's disease by creating more brain-clogging bits known as plaque. Researchers however didn't find any link between high cholesterol and tangles, which also clog the brain in those with Alzheimer's.

13 Sep 2011

A squirt of insulin up the nose for prevention of Alzheimer’s disease

Researchers have noted in a small pilot study that squirting insulin deep into the nose where it travels to the brain might hold early Alzheimer’s disease at bay. At present there are no effective ways to prevent or delay the progress of Alzheimer’s. More than 5.4 million Americans and 35 million people worldwide have Alzheimer's, the most common form of dementia.

13 Sep 2011

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Bayer HealthCare announced today that the company will present data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

13 Sep 2011

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans.

13 Sep 2011

People with high cholesterol more likely to develop Alzheimer's disease

People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.

13 Sep 2011

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Hawthorn Pharmaceuticals, Inc. announced today an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.

13 Sep 2011

Clinical trial planned in Australia and the USA to help patients with ‘orphan’ disease

Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington’s patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington’s often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.

12 Sep 2011

Risks of infectious disease outbreak portrayed in the film 'Contagion' are 'very real'

In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real -- and are increasing drastically."

12 Sep 2011

Lund University professor receives Fernström Foundation Nordic Prize for brain cell transplants

This year's Fernström Foundation Nordic Prize, with prize money of SEK 1 million, goes to Professor Anders Björklund from Lund University, Sweden. He is a neurology researcher focusing on neurodegenerative diseases, diseases in which the nerve cells die. Professor Björklund's research group is trying to develop customised stem cells to treat Parkinson's disease.

12 Sep 2011

Neurology News and Research

Latest Neurology News and Research

Researchers confirm strong bidirectional relation between epilepsy, schizophrenia

ALS damages neurons in parts of the brain responsible for cognition and behaviour

Simple strategies prevent bloodstream infections and save hundreds of patient lives

Policies needed to prepare individuals, society for earlier diagnosis and high risk of Alzheimer's

CHAM experts available to discuss variety of back-to-school issues

Hypnosis to tackle problems of chronic pain: International expert

BGU study: Voting causes stress and induces measurable hormonal changes

Telestroke appears to be cost-effective for rural hospitals

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Researchers discover several chemical compounds against human prion diseases

Jefferson neurologist receives Harold G. Wolff Lecture Award for migraine headache model

High cholesterol and Alzheimer's disease

A squirt of insulin up the nose for prevention of Alzheimer’s disease

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

People with high cholesterol more likely to develop Alzheimer's disease

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Clinical trial planned in Australia and the USA to help patients with ‘orphan’ disease

Risks of infectious disease outbreak portrayed in the film 'Contagion' are 'very real'

Lund University professor receives Fernström Foundation Nordic Prize for brain cell transplants

Industry Focus eBook - Neurology & Neuroscience (1st edition) eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Neurology News and Research

Latest Neurology News and Research

Industry Focus eBook - Neurology & Neuroscience (1st edition) eBook

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Newsletters you may be interested in